Heitner BioInnovation ApS: Financial statements 2023
CVR: 41712937
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Heitner BioInnovation ApS (CVR 41712937) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -1,109 and a net result of DKK -1,109 compared with DKK -600 the year before. Equity in the 2023 report amounted to DKK 18,641. The solvency ratio was 100%.
- Gross Profit
- DKK -1,109
- Profit/Loss
- DKK -1,109
- Equity
- DKK 18,641
- Total Assets
- DKK 18,641
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Heitner BioInnovation ApS has published its annual report for 2022. The net result was DKK -600.
About Heitner BioInnovation ApS
Heitner BioInnovation ApS is a Danish company of the type Anpartsselskab based in Bagsværd, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Tara Renée Heitner. The company is owned by Tara Renée Heitner. In 2025, the company reported a gross profit of DKK -454 and a net result of DKK -454 compared with DKK -1,228 the year before. Equity in the 2025 report amounted to DKK 16,959.